JJJohn K. Jung

John K. Jung

*This is an algorithmically generated author record based on publicly available information.

John K. Jung has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anesthesia and the Art of Communication: A Medical Student Perspective on Humanism in a Technical Specialty

    by James R. Burmeister, John K. Jung, Ismail Zazay

    While anesthesia is frequently characterized by its technical demands and focus on procedural skills, our clinical experiences reveal an equally critical yet often overlooked, need for effective, humanistic communication. Unlike other specialties where rapport builds over time, anesthetists must establish trust, calm fears, and deliver essential information within minutes, often at moments of intense vulnerability for patients. These brief interactions, although fleeting, carry significant emotional and clinical weight. In this perspective, we argue that communication in anesthesia should be treated as a core clinical competency, rather than a peripheral soft skill. We propose low-resource strategies such as brief empathy prompts, simulation debriefs focused on interpersonal tone, and reflective exercises, to help make the hidden curriculum visible. Such interventions not only enhance patient care but also contribute to professional identity formation and may protect against clinician burnout. By elevating the role of communication alongside technical mastery, anesthesia education can better prepare students for the full scope of practice.

  • Open Access

    Reforming Medical Curricula to Support Indigenous Students and Reduce Healthcare Disparities

    by Ismail Zazay, James R Burmeister, John K Jung

    Introduction: Indigenous populations continue to experience health inequities that are exacerbated by systemic barriers in medical education. These challenges both limit the success of Indigenous students and leave the broader physician workforce underprepared to provide culturally safe care. Methods: This narrative literature review explores the educational experiences of Indigenous medical students and examines evidence-informed strategies to enhance cultural competency and inclusion within medical curricula. Studies were identified through database searches using Ovid MEDLINE and relevant MeSH terms, followed by citation chaining. A total of 13 studies were included in the final narrative review. Results: Key themes from the selected literature include structural marginalization in curricula, lack of Indigenous representation, and the emotional burden faced by Indigenous learners. Promising interventions include Indigenous-led simulations, cultural immersion programs, and experiential learning in community settings. However, implementation challenges—such as time constraints, faculty training gaps, and financial barriers—persist. Discussion: A longitudinal, integrated model of cultural humility, embedded throughout medical education, is recommended. Such an approach supports both Indigenous and non-Indigenous learners in delivering more equitable healthcare. Conclusion: Medical education reform must incorporate Indigenous knowledge systems, address institutional racism, and center Indigenous voices to achieve cultural safety and reduce health disparities.


  • Open Access

    Semaglutide as a potential therapeutic adjunct for reducing flare-ups in Sjögren’s syndrome: A case report

    by John Jung, Ismail Zazay, Priya Kalia, Neda Shaghaghi, Nancy Ross, Benjamin Homan

    Sjögren’s syndrome is a chronic autoimmune disorder with limited therapeutic options. Glucagon-like peptide-1 (GLP-1) receptor agonists, primarily used for diabetes and obesity, have emerging evidence of anti-inflammatory and immunomodulatory effects. We present a case of a 37-year-old woman with primary Sjögren’s syndrome and comorbid Hashimoto’s thyroiditis and seronegative rheumatoid arthritis, who experienced frequent debilitating flares affecting her quality of life. After starting semaglutide for weight management and losing over 100 lbs, the patient reported a dramatic reduction in flare frequency and duration, with episodes decreasing from multi-week flares to approximately a single day. This case suggests that semaglutide may offer dual benefits in Sjögren’s syndrome by combining substantial weight reduction with possible direct immunomodulatory effects. Further research is warranted to explore GLP-1 agonists as adjunctive therapy in the management of autoimmune diseases.